Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Allegro Ophthalmics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Allegro Ophthalmics

Allegro Ophthalmics

Private Equity

US-based Allegro Ophthalmics uses Integrin Peptide Therapy to treat vascular eye diseases.

HQ
San Juan Capistrano, CA, US
Founded
2011
Overview
Compare
Fundraising
Employees
Website

Founded in San Juan Capistrano, California, Allegro Ophthalmics LLC is dedicated to advancing ocular care through innovative treatments for vascular eye diseases. The company's core mission is to improve patient outcomes by leveraging Integrin Peptide Therapy, specifically targeting conditions like intermediate dry age-related macular degeneration (AMD). Allegro's flagship product, Risuteganib, is designed to address unmet medical needs in ophthalmology, positioning the company at the forefront of ocular pharmaceutical development.

Notable affiliations include a licensing agreement with AffaMed Therapeutics, which has received Phase CTA approval in China for Risuteganib. Allegro has also achieved significant milestones such as receiving FDA Special Protocol Assessment (SPA) agreement for its Phase 2b/3 clinical trial of Risuteganib. These accomplishments underscore Allegro's impact on the global ophthalmic pharmaceutical market, highlighting its potential to revolutionize treatment paradigms for vascular eye diseases.

Allegro Ophthalmics - Similar Companies

Vitreoretinal Technologies logo

Vitreoretinal Technologies

Alimera Sciences logo

Alimera Sciences

EyeCyte logo

EyeCyte

eyecyte.com

Ocular Therapeutix logo

Ocular Therapeutix

ocutx.com

OcuCure Therapeutics logo

OcuCure Therapeutics

Macuclear logo

Macuclear

Hyperion DeFi logo

Hyperion DeFi

eyenovia.com

Alkeus Pharmaceuticals logo

Alkeus Pharmaceuticals

alkeus.com

MediPrint Ophthalmics logo

MediPrint Ophthalmics

Ocular Science logo

Ocular Science

ocularscience.com

Optherion logo

Optherion

optherion.com

Optovue logo

Optovue

Surface Pharmaceuticals logo

Surface Pharmaceuticals

surfacepharma.com

Aldeyra Therapeutics logo

Aldeyra Therapeutics

Alievio logo

Alievio

Allegro Ophthalmics - Quick Facts

Who are Allegro Ophthalmics' competitors?

Companies similar to Allegro Ophthalmics include Vitreoretinal Technologies, Alimera Sciences, EyeCyte and Ocular Therapeutix.

When was Allegro Ophthalmics founded?

Allegro Ophthalmics was founded in 2011.

Where is Allegro Ophthalmics' headquarters located?

Allegro Ophthalmics' headquarters is located in San Juan Capistrano, CA, US.

When was Allegro Ophthalmics' last funding round?

Allegro Ophthalmics' most recent funding round was for $10.7M (USD) in July 2017.

How much has Allegro Ophthalmics raised to-date?

As of Jul 24, 2017, Allegro Ophthalmics has raised a total of $42.7M (USD).

How many employees does Allegro Ophthalmics have?

Allegro Ophthalmics has 11 employees as of Feb 5, 2024.

Allegro Ophthalmics - Classification

Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research